Treatment of H. pylori Increased Platelet Count in ITP

Eradication of Helicobacter pylori, previously suspected to be associated with the incidence of idiopathic immune thrombocytopenia purpura (ITP), significantly increased platelet counts in adult patients with the condition, according to the results of a small study.1

Among a small group of patients with ITP diagnosed with H. pylori, treatment for the infection yielded a complete or partial response in more than 75% of patients.

The study included 50 patients with chronic ITP who were tested for H. pylori. The infection was diagnosed in 72% of patients, all of whom were treated with triple therapy (omeprazole, amoxicillin, and clarithromycin).

After 6 months, 27.77% (36 of 50) of infected patients showed a complete response and 50% showed a partial response. Among patients who were treated for H. pylori, platelet count increased in 34 patients (94.44%) and decreased in 2 patients.

Looking at those patients who responded to triple therapy, no association between response and patient age or sex was found. However, baseline platelet count and H. pylori infection were associated with achieving a response.

The researchers acknowledged that the role of H. pylori infection in ITP is still unclear.

Want to read more?

CancerTherapyAdvisor.com is a free online resource that offers oncology healthcare professionals a comprehensive knowledge base of practical oncology information and clinical tools to assist in making the right decisions for their patients.

Our mission is to provide practice-focused clinical and drug information that is reflective of current and emerging principles of care that will help to inform oncology decisions.